eIMPAQc System for Cancer Care
(eIMPAQc Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new electronic system called eIMPAQc, designed to help cancer patients and their caregivers report symptoms and manage care more effectively. The system aims to improve communication between patients, caregivers, and healthcare providers through electronic questionnaires and alerts. The trial consists of two parts: before and after using the system to assess its impact on care. Patients receiving cancer care at specific centers who can use email and the internet are well-suited for this trial. As an unphased trial, it offers patients the opportunity to contribute to innovative solutions that could enhance cancer care management.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on electronic patient-reported outcomes rather than medication changes.
What prior data suggests that this eIMPAQc system is safe for cancer care?
Research has shown that the eIMPAQc system is an electronic tool that helps cancer patients and their caregivers report health issues. It collects information through questionnaires, which doctors use to monitor symptoms and manage care more effectively.
As a digital tool rather than a medication or medical procedure, eIMPAQc's safety focuses on ease and comfort of use. Previous users found eIMPAQc easy to use, with no negative effects reported. The program is designed to be simple, aiding patients and caregivers in communicating more clearly with healthcare professionals.
Overall, the eIMPAQc system aims to enhance communication and care without any known risks to users.12345Why are researchers excited about this trial?
Researchers are excited about the eIMPAQc system because it's a new approach to improving cancer care through technology. Unlike traditional treatments that focus solely on medical interventions, eIMPAQc aims to enhance patient outcomes by integrating digital tools to support care delivery. This system is designed to optimize communication between patients and healthcare providers, potentially leading to more personalized and efficient care. By focusing on the overall patient experience, eIMPAQc could revolutionize how care is managed and improve quality of life for cancer patients.
What evidence suggests that the eIMPAQc system is effective for cancer care?
Research has shown that the eIMPAQc system, which uses electronic tools for patients to report symptoms, can greatly improve cancer care. This trial will compare outcomes between patient populations before and after the eIMPAQc roll-out. Studies have found that these tools help lessen symptom severity and improve patient communication with healthcare teams. Patients using eIMPAQc often feel more in control of their care, enhancing their overall quality of life. Evidence also suggests that this system can help patients adhere to treatment plans better and reduce emergency room visits. Overall, eIMPAQc offers promising support in improving experiences and outcomes for cancer patients.35678
Are You a Good Fit for This Trial?
This trial is for cancer patients receiving care at specific centers in Quebec. Participants must be able to speak English or French and use email and the internet.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Pre-implementation
Outcomes collected in patient populations prior to roll-out of the eIMPAQc
Implementation
e-IMPAQc is sequentially rolled out to cancer centres and evaluated
Follow-up
Participants are monitored for outcomes such as patient activation, acceptability, and satisfaction
Post-implementation
Outcomes collected in patient populations after roll-out of eIMPAQc
What Are the Treatments Tested in This Trial?
Interventions
- eIMPAQc
Find a Clinic Near You
Who Is Running the Clinical Trial?
St. Mary's Research Center, Canada
Lead Sponsor